Skip to main content
Erschienen in: AIDS and Behavior 8/2019

08.12.2018 | Original Paper

Demand and Supply Motivations for Antiretroviral Drugs in Illicit Street Markets: The Case of Atlanta, Georgia

verfasst von: Antonio Saravia, Robert Mueller

Erschienen in: AIDS and Behavior | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

We studied the motivations behind supply and demand of antiretroviral drugs (ARVs) in the illicit street markets of the metropolitan statistical area of Atlanta, Sandy Springs, and Roswell, Georgia. We found that these two market actions were largely interdependent: 39.53% of participants said that they sold their ARVs to pay for personal needs, and 20.93% said that they bought ARVs because they had previously sold them to pay for personal needs. The pattern that emerged suggests that illicit street markets have become mechanisms through which HIV patients cooperate to achieve competing goals: cover personal needs and keep up, however imperfectly, with their medication regime. We also found that HIV patients used illicit street markets because they faced institutional deficiencies, such as exclusion from the Ryan White/ADAP program, long waiting times to see a doctor, and prescription delays.
Anhänge
Nur mit Berechtigung zugänglich
Fußnoten
1
The Atlanta MSA’s GDP per capita for 2016 was $55,300 and ranked 50 among 383 MSAs in the U.S. The average MSA GDP per capita that year was $42,276 [12].
 
2
The obvious risk of participating in illicit street markets for ARVs is non-adherence. Selling medication that was part of a strict treatment increases the probability of missing scheduled intakes. Buying ARVs without a prescription or the supervision of pharmacists or medical personnel increases the probabilities of taking the wrong medication, taking expired medication and/or using wrong doses.
 
3
This methodological approach is commonly used to identify and recruit potential participants that are difficult to reach [1821].
 
4
Although we had not surveyed HIV patients before this study, we both had ample experience conducting qualitative research.
 
5
This aspect of our sample did not occur by design. Every person who called interested in participating of the study was African American. HIV in the Atlanta MSA is most prevalent in the African-American population.
 
6
Georgia’s ADAP is a state-administered program that provides ARVs to lower income individuals who live with HIV but have no insurance coverage except for Medicare. ADAPs across the country were originally authorized by the Ryan White Comprehensive AIDS Resources Emergency Act of 1990. ADAP funds are used only for the purchase of ADAP formulary drugs that patients cannot afford through other means (i.e., ADAP must be the payer of last resort). There are currently 74 medications on the Georgia ADAP Formulary. Georgia’s ADAP services are available to all eligible residents in the state: 27 enrollment sites in 18 public health districts, including 7 sites in metro Atlanta alone [24].
 
7
We defined “illegal drugs” as any drug listed in Schedules I or II of the Drug Enforcement Administration’s Resource Guide [25].
 
8
The most frequently cited personal needs included food, transportation and family support. Most participants did not have a stable job and 13.95% (n = 6) of them did not have a permanent residence.
 
9
All Ryan White/ADAP participants are required to recertify their eligibility for the program every six months [24].
 
10
One of the eligibility criteria required participants to be under formal treatment (defined as having obtained a prescription within the previous six months). Eight of our participants (18.60%) had obtained prescriptions within the previous six months yet reported having no insurance coverage. The reason is that they had received their prescriptions in a different state but had recently moved to the Atlanta MSA and were in the process of gathering documentation to be admitted into the Ryan White/ADAP program.
 
11
A list of outreach and charitable HIV/AIDS programs can be found at the Positive Impact Health Centers website [27].
 
12
The MSA of Miami–Fort Lauderdale–West Palm Beach, Florida, ranked number 1 in HIV diagnostic rates in 2016 out of 108 MSAs with a rate of 38.7 per 100,000. Recall that the Atlanta MSA ranked third in diagnostic rates that year with a rate of 29.4 per 100,000 [13].
 
Literatur
1.
Zurück zum Zitat Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.CrossRefPubMed Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.CrossRefPubMed
2.
Zurück zum Zitat Associated Press. AIDS drugs surface on the black market. New York Times. 1995. Associated Press. AIDS drugs surface on the black market. New York Times. 1995.
3.
Zurück zum Zitat Dorschner J. Activists: HIV care scam uses homeless. Miami Herald. 2005;30:2005. Dorschner J. Activists: HIV care scam uses homeless. Miami Herald. 2005;30:2005.
4.
Zurück zum Zitat Flaherty M, Gaul G. Florida Medicaid fraud costs millions, report says. Washington Post. 2003;19:2003. Flaherty M, Gaul G. Florida Medicaid fraud costs millions, report says. Washington Post. 2003;19:2003.
5.
Zurück zum Zitat Glasgow K. The new dealers: they’re poor, black, and HIV-positive. Their product? The AIDS medications intended to cure them. Miami New Times. 1999;21:1999. Glasgow K. The new dealers: they’re poor, black, and HIV-positive. Their product? The AIDS medications intended to cure them. Miami New Times. 1999;21:1999.
6.
Zurück zum Zitat Tsuyuki K, Surratt H, Levi-Minzi M, O’Grady C, Kurtz S. The demand for antiretroviral drugs in the illicit marketplace: implications for HIV disease management among vulnerable populations. Aids Behav. 2014;19:857–68.CrossRef Tsuyuki K, Surratt H, Levi-Minzi M, O’Grady C, Kurtz S. The demand for antiretroviral drugs in the illicit marketplace: implications for HIV disease management among vulnerable populations. Aids Behav. 2014;19:857–68.CrossRef
7.
Zurück zum Zitat Surratt H, Kurtz S, Levi-Minzi M, Chen M. Environmental influences on HIV medication adherence: the role of neighborhood disorder. Am J Public Health. 2015;105(8):1660–6.CrossRefPubMedPubMedCentral Surratt H, Kurtz S, Levi-Minzi M, Chen M. Environmental influences on HIV medication adherence: the role of neighborhood disorder. Am J Public Health. 2015;105(8):1660–6.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Surratt H, Kurtz S, Levi-Minzi M, Tsuyuki K, O’Grady C. Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive. AIDS Patient Care STDs. 2015;29(4):186–92.CrossRefPubMedPubMedCentral Surratt H, Kurtz S, Levi-Minzi M, Tsuyuki K, O’Grady C. Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive. AIDS Patient Care STDs. 2015;29(4):186–92.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Surratt H, Kurtz S, Cicero T, O’Grady C, Levi-Minzi M. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health. 2013;103(6):1026–8.CrossRefPubMedPubMedCentral Surratt H, Kurtz S, Cicero T, O’Grady C, Levi-Minzi M. Antiretroviral medication diversion among HIV-positive substance abusers in South Florida. Am J Public Health. 2013;103(6):1026–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Surratt H, O’Grady C, Levi-Minzi M, Kurtz S. Medication adherence challenges among HIV-positive substance abusers: the role of food and housing insecurity. AIDS Care. 2015;27(3):307–14.CrossRefPubMed Surratt H, O’Grady C, Levi-Minzi M, Kurtz S. Medication adherence challenges among HIV-positive substance abusers: the role of food and housing insecurity. AIDS Care. 2015;27(3):307–14.CrossRefPubMed
11.
Zurück zum Zitat Levi-Minzi M, Surratt H. HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment. AIDS Patient Care STDs. 2014;28(8):442–51.CrossRefPubMedPubMedCentral Levi-Minzi M, Surratt H. HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment. AIDS Patient Care STDs. 2014;28(8):442–51.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Staples G. Despite progress, Atlanta’s HIV epidemic is worse. Atlanta J. Const. 2017;30:2017. Staples G. Despite progress, Atlanta’s HIV epidemic is worse. Atlanta J. Const. 2017;30:2017.
17.
Zurück zum Zitat Georgia Department of Public Health, HIV/AIDS Epidemiology Program. HIV care continuum surveillance report, Georgia, 2014. 2016. https://dph.georgia.gov. Accessed 28 Dec 2017. Georgia Department of Public Health, HIV/AIDS Epidemiology Program. HIV care continuum surveillance report, Georgia, 2014. 2016. https://​dph.​georgia.​gov. Accessed 28 Dec 2017.
18.
Zurück zum Zitat Braunstein M. Sampling a hidden population: noninstitutionalized drug users. AIDS Educ Prev. 1993;5(2):131–9.PubMed Braunstein M. Sampling a hidden population: noninstitutionalized drug users. AIDS Educ Prev. 1993;5(2):131–9.PubMed
19.
Zurück zum Zitat Watters J, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36(4):416–30.CrossRef Watters J, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36(4):416–30.CrossRef
20.
Zurück zum Zitat Carlson R, Wang J, Siegal H, Falck R, Guo J. An ethnographic approach to targeted sampling: problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Hum Organ. 1994;53(3):279–86.CrossRef Carlson R, Wang J, Siegal H, Falck R, Guo J. An ethnographic approach to targeted sampling: problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Hum Organ. 1994;53(3):279–86.CrossRef
21.
Zurück zum Zitat Coyle S. Women’s drug use and HIV risk: findings from NIDA’s cooperative agreement for community-based outreach/intervention research program. Women Health. 1998;27(1/2):1–18.CrossRefPubMed Coyle S. Women’s drug use and HIV risk: findings from NIDA’s cooperative agreement for community-based outreach/intervention research program. Women Health. 1998;27(1/2):1–18.CrossRefPubMed
22.
Zurück zum Zitat Abbott A. Methods of discovery: heuristics for the social sciences. New York: Norton; 2004. Abbott A. Methods of discovery: heuristics for the social sciences. New York: Norton; 2004.
23.
Zurück zum Zitat Strauss A, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Thousand Oaks: Sage Publications; 1990. Strauss A, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Thousand Oaks: Sage Publications; 1990.
24.
Zurück zum Zitat Georgia Department of Public Health, Division of Health Protection. Georgia Ryan White Part B, AIDS Drug Assistance Program (ADAP), and Health Insurance Continuation Program (HICP) Policies & Procedures 2017. 2017. Georgia Department of Public Health, Division of Health Protection. Georgia Ryan White Part B, AIDS Drug Assistance Program (ADAP), and Health Insurance Continuation Program (HICP) Policies & Procedures 2017. 2017.
25.
Zurück zum Zitat U.S. Department of Justice, Drug enforcement Administration. Drugs of Abuse: A DEA Resource Guide. 2017. U.S. Department of Justice, Drug enforcement Administration. Drugs of Abuse: A DEA Resource Guide. 2017.
26.
Metadaten
Titel
Demand and Supply Motivations for Antiretroviral Drugs in Illicit Street Markets: The Case of Atlanta, Georgia
verfasst von
Antonio Saravia
Robert Mueller
Publikationsdatum
08.12.2018
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 8/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2359-z

Weitere Artikel der Ausgabe 8/2019

AIDS and Behavior 8/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.